| Launch of Phase 3 clinical trial with Nefecon in Japan | 07/04 03:20 | prnewswire.com |
| Calliditas provides setanaxib patent update | 06/18 06:23 | prnewswire.com |
| Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ) | 06/17 12:01 | prnewswire.com |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT on Behalf of Shareholders | 06/06 13:00 | accesswire.com |
| STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger and Expiring Tender Offer - AKLI and CALT | 06/06 12:15 | accesswire.com |
| STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 18, 2024, for shares of Calliditas Therapeutics AB – CALT | 06/05 14:12 | globenewswire.com |
| SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate MODN, CALT | 06/04 20:15 | accesswire.com |
| STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 18, 2024, for shares of Calliditas Therapeutics AB - CALT | 06/04 19:26 | prnewswire.com |
| Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathy | 05/30 14:18 | prnewswire.com |
| Calliditas Therapeutics' stock surges after $1.1 billion takeover bid | 05/28 08:58 | marketwatch.com |